Microsoft Corporation (NASDAQ: MSFT) shares rose about 1% to $535.11 in Thursday's premarket trading after the company reported better-than-expected...
Moderna (NASDAQ: MRNA) shares plunged more than 17% to $202.63 in Thursday's regular trading session after detailed Phase 3 results for its personalized melanoma...